NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Quenna PMQ? Mail in a sample (US only) and let us test it.

Test my supply
72%
Finnrick rating
#267 of 457 ranked vendors
15 of 22 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Quenna PMQ's Purity focus evidence is current but volatile, with recent clean Tirzepatide and Retatrutide identity, purity, and fill passes offset by major failures. Tirzepatide recovered after a 0 mg identity/quantity failure, while Retatrutide has a recent 0 mg identity fail, severe underfill, and spotty batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Quenna PMQ

We investigated who actually operates Quenna PMQ — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages8 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.50
75%
11
2
Retatrutide
$6.67
70%
10
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%16 Jul 2025: 65%5 Aug 2025: 71%1 Oct 2025: 80%5 Oct 2025: 78%23 Oct 2025: 75%29 Oct 2025: 74%18 Nov 2025: 75%18 Nov 2025: 76%5 Dec 2025: 74%6 Dec 2025: 74%13 Dec 2025: 74%13 Dec 2025: 73%29 Dec 2025: 74%1 Jan 2026: 74%26 Jan 2026: 75%18 Feb 2026: 74%2 Mar 2026: 74%29 Mar 2026: 75%23 Apr 2026: 74%23 Apr 2026: 72%1 Jun 2026: 73%24 Sep 2026: 72%2 Oct 2026: current 72%65%73%72%Jul 25Oct 26
Free peptide testing

Ordered peptides from Quenna PMQ? Mail in a sample (US only) and let us test it.

Test my supply
Quenna PMQ test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Sep 2026
Fail
Retatrutide
lab nameView COA
1 Jun 2026
Pass
Tirzepatide
lab nameView COA
23 Apr 2026
Fail
Retatrutide
lab nameView COA
23 Apr 2026
Fail
Tirzepatide
lab nameView COA
29 Mar 2026
Pass
Retatrutide
lab nameView COA
2 Mar 2026
Pass
Tirzepatide
lab nameView COA
18 Feb 2026
Fail
Tirzepatide
lab nameView COA
26 Jan 2026
Pass
Tirzepatide
lab nameView COA
1 Jan 2026
Pass
Retatrutide
lab nameView COA
29 Dec 2025
Pass
Retatrutide
lab nameView COA
1-10 of 22

About Quenna PMQ test results from Finnrick

Quenna PMQ is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 22 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Quenna PMQ peptides in this dataset are Retatrutide (10 tests), Semaglutide (1 test) and Tirzepatide (11 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 22 recent tests. It also includes 1 correction related to this vendor.

Corrections
2025-12-26
Customer update
Submitter indicated having swapped vendor identification with sample yauaeu5. This should be Quenna PMQ instead of OUPeptide. Evidence under review, ratings might be updated.
Free peptide testing

Ordered peptides from Quenna PMQ? Mail in a sample (US only) and let us test it.

Test my supply